The finding of novel molecular markers for prediction or prognosis of invasiveness in colorectal cancer (cRc) constitutes an appealing challenge. Here we show the up-regulation of EPDR1 in a prospective cohort of 101 CRC patients, in a cDNA array of 43 patients and in in silico analyses. EPDR1 encodes a protein related to ependymins, a family of glycoproteins involved in intercellular contacts. A thorough statistical model allowed us to conclude that the gene is significantly up-regulated in tumour tissues when compared with normal mucosa. these results agree with those obtained by the analysis of three publicly available databases. EPDR1 up-regulation correlates with the tnM staging parameters, especially t and M. Studies with cRc cell lines revealed that the methylation of a cpG island controls EPDR1 expression. siRNA knocking-down and overexpression of the gene following transient plasmid transfection, showed that EPDR1 favours cell proliferation, migration, invasiveness and adhesion to type I collagen fibres, suggesting a role in epithelial to mesenchymal transition. Both statistical and functional analysis correlated EPDR1 overexpression with invasiveness and dissemination of tumour cells, supporting the inclusion of EPDR1 in panels of genes used to improve molecular subtyping of cRc. eventually, EPDR1 may be an actionable target. Colorectal cancer (CRC) is one of the most common malignancies worldwide 1. In spite of the progresses of precision medicine, the long-term survival of patients with advanced metastatic disease is still poor 2 and the burden of CRC is expected to increase by 60% in the next decade 1. Nevertheless, this disease is a good candidate for screening programmes 3 and its early detection improve treatment and survival. Most of CRC-related death is due to tumour metastasis 4 and, therefore, finding of molecular markers for prediction or prognosis of invasiveness, which could be added to the available repertoire of potential markers 5-7 , constitutes an appealing challenge. This is particularly attractive in view of the growing interest in improving the clinical stratification of CRC 8,9. This reason, together with the risks of metastatic dissemination, makes especially interesting the identification of potential actionable targets in CRC. The EPDR1 gene codes for a protein related to ependymins, a family of piscine brain glycoproteins 10. Ependymins, encoded by Epd genes, are transmembrane proteins that play a role in intercellular contacts between neural cells 11. It was early suggested that their extracellular domain may display antiadhesive properties 12 and it shows a calcium-dependent ability to interact with collagen fibrils 13 .